Fargesin improves lipid and glucose metabolism in 3T3-L1 adipocytes and high-fat diet-induced obese mice

BioFactors

Volumn 38, Issue 4, 2012, Pages 300-308

  Lee, Young Sil ^a   Cha, Byung Yoon ^a   Choi, Sun Sil ^a   Harada, Yumiko ^a   Choi, Bong Keun ^a   Yonezawa, Takayuki ^a   Teruya, Toshiaki ^b   Nagai, Kazuo ^a   Woo, Je Tae ^a  

^a CHUBU UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Akt and AMPK activation; Fargesin; High fat diet induced obese mice; Lipid and glucose metabolism; Obesity

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CARNITINE PALMITOYLTRANSFERASE I; FARGESIN; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN KINASE B; ROSIGLITAZONE; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 2;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; DYSLIPIDEMIA; ENZYME ACTIVATION; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FOOD INTAKE; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

3T3-L1 CELLS; ACETYL-COA CARBOXYLASE; ADENYLATE KINASE; ADIPOCYTES; ANIMALS; BENZODIOXOLES; BLOOD GLUCOSE; DIET, HIGH-FAT; GENE EXPRESSION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LIGNANS; LIPID METABOLISM; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; ORGAN SIZE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; WEIGHT GAIN;

MAGNOLIA; MUS;

EID: 84865110809     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1022     Document Type: Article

References (32)

1. Spieglman, B. M. and Filer, J. S. ( 2001) Obesity and the regulation of energy balance. Cell 104, 531-543.
2. Schenk, S., Saberi, M., and Olefsky, J. M. ( 2008) Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 118, 2992-3002.
3. Erickson, J. W. ( 2007) Metabolic stress in insulin's target cells leads to ROS accumulation: a hypothetical common pathway causing insulin resistance. FEBS Lett. 581, 3734-3742.
4. Shen, Y., Li, C. G., Zhou, S. F., Pang, E. C., Story, D. F., and Xue, C. C. ( 2008) Chemistry and bioactivity of Flos Magnoliae, a Chinese herhinitis and sinusitis. Curr. Med. Chem. 15, 1616-1627.
5. Zhao, W., Zhou, T., Fan, G., Chai, Y., and Wu, Y. ( 2007) Isolation and purification of lignans from: magnolia biondii Pamp by isocratic reversed-phase two-dimensional liquid chromatography following microwave-assisted extraction. J. Sep. Sci. 30, 2370-2381.
6. Baek, J. A., Lee, Y. D., Lee, C. B., Go, H. K., Kim, J. P., Seo, J. J., Rhee, Y. K., and Kim, D.J. ( 2009) Extracts of Magnoliae flos inhibit inducible nitric oxidae synthese via ERK in human respiratory epithelial cells. Nitric Oxide 20, 122-128.
7. Kim, J. S., Kim, J. Y., Lee, H. J., Lim, H. J., Lee, D. Y., Kim, D. H., and Ryu, J. H. ( 2009) Suppression of inducible nitric oxide synthase expression by furfran lignans from flower buds of Magnolia fargesii in BV-2 microglial cells. Phytother. Res. 24, 748-753.
8. Lim, H., Son, K. H., Bae, K. H., Hung, T. M., Kim, Y. S., and Kim, H. P. ( 2009) 5-Lipoxygenase-inhibitory constituents from Schizandra fructus and Magnolia flos. Phytother. Res. 23, 1489-1492.
9. Kim, Y. G., Ozawa, S., Sano, Y., and Sasaya, T. ( 1996) Extractives of kitakobusi Magnolis kobus DC. Varborealis Sarg. II: Distribution in tree and seasonal variation in leaves of lignans. Res. Bull Hokkaido Univ. Forests 53, 1-28.
10. Gonzalez, E. and McGrew, T. E. ( 2010) Insulin signaling diverges into Akt-dependent and -independent signals to regulate the recruitment/docking and the fusion of GLUT4 vesicles to the plasma membrane. Mol. Biol. Cell. 21, 1375-1386.
11. Karnieli, E. and Armoni, M. ( 2008) Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology. Am. J. Physiol. Endocrinol. Metab. 295, E38-E45.
12. Hers, I. and Tavare, J. M. ( 2005) Mechanism of feedback regulation of insulin receptor substrate-1 phosphorylation in primary adipocytes. Biochem. J. 388, 713-720.
13. Zaid, H., Antonescu, C. N., Randhawa, V. K., and Klip, A. ( 2008) Insulin action on glucose transporters through molecular switches, tracks and tethers. Biochem. J. 413, 201-215.
14. Kohn, A. D., Summers, S. A., Birnbaum, M. J., and Roth, R. A. ( 1996) Expression of a constitutively active Akt/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271, 31372-31378.
15. Hill, M. M., Clark, S. F., Trucker, D. F., Birnbaum, M. J., James, D. E., and Macaulay, S. L. ( 1999) A role for protein kinases B beta/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes. Mol. Cell. Biol. 19, 7771-7781.
16. Wang, Q., Somwar, R., Bilan, P. J., Liu, Z., Jin, J., Woodgett, J. R., and Klip, A. ( 1999). Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblast. Mol. Cell. Biol. 19, 4008-4018.
17. Huang, S. and Czech, M. P. ( 2007) The GLUT4 glucose transporter. Cell Metab. 5, 237-252.
18. Hardie, D. G. and Pan, D. A. ( 2002) Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem. Soc. Trans. 30, 1064-1070.
19. Zhang, B. B., Zhou, G., and Li, C. ( 2009) AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 9, 407-416.
20. Ruderman, N. and Prentki, M. ( 2004) AMP kinase and malnoy-CoA: target for therapy of the metabolic sysndrome. Nat. Rev. Drug. Discov. 3, 340-351.
21. Yamauchi, T., Kamon, J., Waki, H., Murakami, K., Motojima, K., Komeda, K., Ide, T., Kubota, N., Terauchi, Y., Tobe, K., Mili, H., Tsuchida, A., Akanuma, Y., Nagai, R., Kimura, S., and Kadowaki, T. ( 2001) The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance. J. Biol. Chem. 276, 41245-41254.
22. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M. F., Goodyear, L. J., and Moller, D. E. ( 2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174.
23. Ma, X., Egawa, T., Kimura, H., Karaike, K., Masuda, S., Iwanaka, N., and Hayashi, T. ( 2010) Berberine-induced activation of 5′-adenosine monophosphate-activated protein kinase and glucose transport in rat skeletal muscles. Metabolism 59, 1619-1627.
24. Takikawa, M., Inoue, S., Horio, F., and Tsuda, T. ( 2010) Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J. Nutr. 140, 527-533.
25. Laws, A. ( 1996) Free fatty acids, insulin resistance and lipoprotein metabolism. Curr. Opin. Lipidol. 7, 172-177.
26. Boden, G., Chen, X., Ruiz, J., White, J. V., Rossetti, L. ( 1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93, 2438-2446.
27. Staehr, P., Hother-Nielsen, O., Landau, B. R., Chandramouli, V., Holst, J. J., Beck-Nielsen, H. ( 2003) Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes 52, 260-267.
28. Daval, M., Foufelle, F., and Ferré, P. ( 2006) Functions of AMP-activated protein kinase in adipose tissue. J. Physiol. 574, 55-62.
29. Guerre-Millo, M., Gervois, P., Raspé, E., Madsen, L., Poulain, P., Derudas, B., Herbert, J. M., Winegar, D. A., Willson, T. M., Fruchart, J. C., Berge, R. K., and Staels, B. ( 2000) Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J. Biol. Chem. 275, 16638-16642.
30. Gao, X., Li, K., Hui, X., Kong, X., Sweeney, G., Wang, Y., Xu, A., Teng, M., Liu, P., and Wu, D. ( 2011) Carnitine palmitoyltransferase 1A prevents fatty acid-induced adipocyte dysfunction through suppression of c-Jun N-terminal kinase. Biochem. J. 435, 723-732.
31. Fleury, C., Neverova, M., Collins, S., Raimbault, S., Champigny, O., Levi-Meyrueis, C., Bouillaud, F., Seldin, M. F., Surwit, R. S., Ricquier, D., and Warden, C. H. ( 1997) Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat. Genet. 15, 269-272.
32. Ahima, R. S. ( 2006) Adipose tissue as an endocrine organ. Obesity 14, 242S-249S.